What is Tarsus Pharmaceuticals, Inc.'s income tax?

Tarsus Pharmaceuticals, Inc. (TARS) reported income tax of $2.35M in Q1 2026.

What is the long-term trend for Tarsus Pharmaceuticals, Inc.'s income tax?

Over 3 years (2021 to 2024), Tarsus Pharmaceuticals, Inc.'s income tax has grown at a -100.0% compound annual growth rate (CAGR), from $55K to $0.

What does income tax mean?

Total income tax expense (current + deferred) recognized in the income statement, representing the company's total tax obligation on pre-tax income.

Tarsus Pharmaceuticals, Inc. TARS Income Tax

Income Tax at other companies

AbbVieABBV

$342M-8.1%

Bausch + LombBLCO

$6M-80.6%

Warby ParkerWRBY

$821K-43.5%

Regeneron PharmaceuticalsREGN

$104M+8.0%

GlaukosGKOS

$484K+48.5%

Segments

By segment

See full

Reportable Segment-$2.35M—

Other financials

Income statement

See full

Revenue$162.1M+107%

Gross profit$152.7M+109%

Operating income-$6.1M+76.7%

Net income-$7.0M+72.3%

EPS (diluted)-$0.16+75.0%

Balance sheet

See full

Cash & equivalents$104.2M-41.6%

Total debt$88.7M+22.5%

Total equity$349.0M+1.9%

Total assets$581.1M+16.1%

Cash flow

See full

Operating cash flow-$24.7M-19.4%

CapEx$5.8M+886%

Free cash flow-$30.5M-43.4%

Valuation

See full

Market cap$2.85B+41.1%

Enterprise value$2.83B+47.8%

P/S5.3×-3.3×

Profitability

See full

Gross margin42.7%—

Operating margin-9.5%-4.2pp

Net margin-9%-4.0pp

FCF margin-28%-12.6pp

Returns & leverage

See full

Return on equity-14%-5.2pp

Debt / equity0.3×0.0×

Current ratio3.7×-1.8×

Where this comes from

Reported directly by Tarsus Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncomeTaxExpenseBenefit.

The official record: Tarsus Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Tarsus Pharmaceuticals, Inc.'s income tax.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Tarsus Pharmaceuticals, Inc.'s income tax?: Tarsus Pharmaceuticals, Inc. (TARS) reported income tax of $2.35M in Q1 2026.
What is the long-term trend for Tarsus Pharmaceuticals, Inc.'s income tax?: Over 3 years (2021 to 2024), Tarsus Pharmaceuticals, Inc.'s income tax has grown at a -100.0% compound annual growth rate (CAGR), from $55K to $0.
What does income tax mean?: Total income tax expense (current + deferred) recognized in the income statement, representing the company's total tax obligation on pre-tax income.